Dr. Lance Liotta Laboratory via Wikimedia Commons // Public Domain
Dr. Lance Liotta Laboratory via Wikimedia Commons // Public Domain

A New Vaccine for Chlamydia Is in the Works

Dr. Lance Liotta Laboratory via Wikimedia Commons // Public Domain
Dr. Lance Liotta Laboratory via Wikimedia Commons // Public Domain

Creating a successful vaccine is exceedingly difficult, which makes it all the more remarkable that we have managed to develop so many of them, saving millions of lives. But one widespread disease has long eluded scientists' best efforts to stop it: chlamydia.  

Despite years of development, no vaccine successfully prevents Chlamydia trachomatis, the bacteria that is the leading cause of sexually transmitted infections around the globe. Worldwide, there are an estimated 106 million cases of the disease every yearLeft untreated, it can cause infertility, pelvic inflammatory disease, chronic pelvic pain, infant pneumonia, and more. C. trachomatis is also one of the leading causes of preventable blindness, and can be spread during childbirth and through sharing washcloths.

The infection can be cured fairly easily with antibiotics, but not everyone who has it presents symptoms, and once you’re treated, you can be re-infected. A vaccine could stop chlamydia—including related strains that infect animals—from ever spreading in the first place.

Now, scientists from Harvard University think they’ve figured out why chlamydia has been so hard to develop a vaccine for. As they report in the journal Science, immune response cells known as T cells are to blame. As a result of this insight, they're working on a new vaccine.

Dead chlamydia cells were used in the first efforts to develop a vaccine in the 1960s. What scientists didn't know then is that the white blood cells known as T cells were preventing the immune system from activating to fight the infection. So instead of protecting the body, the T cells became an anti-inflammatory agent that instead protected the infecting bacteria. Not only did these early vaccines not prevent chlamydia infections, they actually made subsequent chlamydia infections worse.

The testing of these vaccines in the 1960s on children in India, Saudi Arabia, and Ethiopia was largely a bust. Sometimes they worked, but were only effective for a single year. There was some evidence that a vaccine reduced eye scarring on kids with chlamydia eye infections. But scientists couldn't figure out why the vaccines exacerbated symptoms in some cases [PDF], and eventually the research petered out.

Now the Harvard team is developing a new vaccine that takes into account the T cells' behavior. This new vaccine utilizes an nanoparticle adjuvant—which is designed to increase the immune response in a patient—to help the body’s T cells recognize that chlamydia bacteria need to be fought off, not protected.

It’s also designed to be applied to the nasal cavity, because they found that the vaccine is better transmitted through mucus membranes—which are also most likely to be affected by chlamydia—than through the skin. So you may spray a chlamydia vaccine up your nose one day. 

The vaccine won’t be available for human testing for a few years, but trials in mice showed that a nasal spray elicited an immune response against chlamydia for up to six months. After the HPV vaccine (which has recently been tied to fewer precancerous cervical lesions) and vaccines for hepatitis A and B, a chlamydia vaccine would only be one of only a few inoculations available for sexually transmitted infections. Scientists are also working on a vaccine against HIV. Say it with me: shots, shots, shots, shots, shots! (Everybody should get them.)

[h/t: The Verge]

Jamie McCarthy/Getty Images for Bill & Melinda Gates Foundation
Bill Gates is Spending $100 Million to Find a Cure for Alzheimer's
Jamie McCarthy/Getty Images for Bill & Melinda Gates Foundation
Jamie McCarthy/Getty Images for Bill & Melinda Gates Foundation

Not everyone who's blessed with a long life will remember it. Individuals who live into their mid-80s have a nearly 50 percent chance of developing Alzheimer's, and scientists still haven't discovered any groundbreaking treatments for the neurodegenerative disease [PDF]. To pave the way for a cure, Microsoft co-founder and philanthropist Bill Gates has announced that he's donating $100 million to dementia research, according to Newsweek.

On his blog, Gates explained that Alzheimer's disease places a financial burden on both families and healthcare systems alike. "This is something that governments all over the world need to be thinking about," he wrote, "including in low- and middle-income countries where life expectancies are catching up to the global average and the number of people with dementia is on the rise."

Gates's interest in Alzheimer's is both pragmatic and personal. "This is something I know a lot about, because men in my family have suffered from Alzheimer’s," he said. "I know how awful it is to watch people you love struggle as the disease robs them of their mental capacity, and there is nothing you can do about it. It feels a lot like you're experiencing a gradual death of the person that you knew."

Experts still haven't figured out quite what causes Alzheimer's, how it progresses, and why certain people are more prone to it than others. Gates believes that important breakthroughs will occur if scientists can understand the condition's etiology (or cause), create better drugs, develop techniques for early detection and diagnosis, and make it easier for patients to enroll in clinical trials, he said.

Gates plans to donate $50 million to the Dementia Discovery Fund, a venture capital fund that supports Alzheimer's research and treatment developments. The rest will go to research startups, Reuters reports.

[h/t Newsweek]

A New Analysis of Chopin's Heart Reveals the Cause of His Death

For years, experts and music lovers alike have speculated over what caused celebrated composer Frederic Chopin to die at the tragically young age of 39. Following a recent examination of his heart, Polish scientists have concluded that Chopin succumbed to tuberculosis, just as his death certificate states, according to The New York Times.

When Chopin died in 1849, his body was buried in Paris, where he had lived, while his heart was transported to his home city of Warsaw, Poland. Chopin—who appeared to have been ill with tuberculosis (TB)—was terrified of the prospect of being buried alive, and nostalgic for his national roots. He asked for his heart to be cut out, and his sister later smuggled it past foreign guards and into what is now Poland.

Preserved in alcohol—likely cognac—and stored in a crystal jar, Chopin's heart was laid to rest inside Holy Cross Church in Warsaw. (It was removed by the Germans in 1944 during the Warsaw Uprising, and later returned.) But rumors began to swirl, as the same doctor tasked with removing the heart had also conducted an autopsy on the composer's body, according to the BBC.

The physician's original notes have been lost, but it's said he concluded that Chopin had died not from TB but from "a disease not previously encountered." This triggered some scholars to theorize that Chopin had died from cystic fibrosis, or even a form of emphysema, as the sickly musician suffered from chronic respiratory issues. Another suspected condition was mitral stenosis, or a narrowing of the heart valves.

Adhering to the wishes of a living relative, the Polish church and government have refused to let scientists conduct genetic tests on Chopin's heart. But over the years, teams have periodically checked up on the organ to ensure it remains in good condition, including once in 1945.

In 2014, a group of Chopin enthusiasts—including Polish scientists, religious officials, and members of the Chopin Institute, which researches and promotes Chopin's legacy—were given the go-ahead to hold a clandestine evening meeting at Holy Cross Church. There, they removed Chopin's heart from its perch inside a stone pillar to inspect it for the first time in nearly 70 years.

Fearing the jar's alcohol would evaporate, the group added hot wax to its seal and took more than 1000 photos of its contents. Pictures of the surreptitious evening procedure weren't publicly released, but were shown to the AP, which described Chopin's preserved heart as "an enlarged white lump."

It's unclear what prompted a follow-up investigation on Chopin's heart, or who allowed it, but an early version of an article in the American Journal of Medicine states that experts—who did not open the jar—have newly observed that the famed organ is "massively enlarged and floppy," with lesions and a white, frosted appearance. These observations have prompted them to diagnose the musician's cause of death as pericarditis, which is an inflammation of tissue around the heart. This likely stemmed from his tuberculosis, they said.

Some scientists might still clamor at the prospect of testing tissue samples of Chopin's heart. But Michael Witt of the Polish Academy of Sciences—who was involved in this latest examination—told The Guardian that it was unnecessary to disturb what many consider to be a symbol of national pride.

"Some people still want to open it in order to take tissue samples to do DNA tests to support their ideas that Chopin had some kind of genetic condition," Witt said. "That would be absolutely wrong. It could destroy the heart, and in any case, I am quite sure we now know what killed Chopin."

[h/t The New York Times]


More from mental floss studios